Brief: Rhythm Biosciences Says Colostat® Authorised For Sale In New Zealand
03/11/2022 01:11
Nov 3 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* COLOSTAT® AUTHORISED FOR SALE IN NEW ZEALAND
* PRE-SALES AND COMMERCIAL PARTNERSHIP DISCUSSIONS ARE
PROGRESSING
WITH AIM OF QUICKLY MAKING COLOSTAT AVAILABLE FOR USE
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt